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Abstract: The present study aimed to evaluate the synergistic effects of the crude ethyl acetate
extract (CEAE) from endophytic actinomycete MPT42 and essential oil (EO) of the same host plant
Litsea cubeba. The isolate MPT42, exhibiting broad-spectrum antimicrobial activities and harboring
all three antibiotic-related biosynthetic genes pks-I, pks-II, and nrps, was identified as Streptomycete
griseorubens based on an analysis of the morphology, physiology, and 16S rDNA sequence. Minimum
inhibitory concentrations (MICs) and the fractional inhibitory concentration index were used to
estimate the synergistic effects of various combined ratios between CEAE or antibiotics (erythromycin,
vancomycin) and EO toward 13 microbial strains including pathogens. L. cubeba fruit EO, showing
the main chemical constituents of 36.0% citral, 29.6% carveol, and 20.5% limonene, revealed an
active-low against tested microbes (MICs ≥ 600 µg/mL). The CEAE of S. griseorubens culture exhibited
moderate–strong antimicrobial activities against microbes (MICs = 80–600 µg/mL). Analysis of the
mechanism of action of EO on Escherichia coli ATCC 25922 found that bacterial cells were dead after
7 h of the EO treatment at 1 MIC (5.5 mg/mL), where 62% cells were permeabilized after 2 h and
3% of them were filament (length ≥ 6 µm). Combinations of CEAE, erythromycin, or vancomycin
with EO led to significant synergistic antimicrobial effects against microbes with 4–16 fold reduction
in MIC values when compared to their single use. Interestingly, the vancomycin–EO combinations
exhibited a strong synergistic effect against five Gram-negative bacterial species. This could assume
that the synergy was possibly due to increasing the cell membrane permeability by the EO acting
on the bacterial cells, which allows the uptake and diffusion of antimicrobial substances inside the
Antibiotics 2019, 8, 197; doi:10.3390/antibiotics8040197 www.mdpi.com/journal/antibiotics
Antibiotics 2019, 8, 197 2 of 14
cell easily. These findings in the present study therefore propose a possible alternative to combat the
emergence of multidrug-resistant microbes in veterinary and clinics.
Keywords: antimicrobial activity; endophytic actinomycete; essential oil; medicinal plants; membrane
permeability; Litsea cubeba; synergistic effect and Streptomyces griseorubens
1. Introduction
The misuse and overuse of antibiotics for human and animal health management has become
a main factor contributing to the rapid emergence and dissemination of antibiotic-resistant bacteria,
which poses a serious threat to global public health [1]. Consequently, antibiotic resistance increases
the cost of healthcare, the risk of treatment failure, and the fatality rate. Thus, the findings of novel
antimicrobial agents and alternative therapeutic strategies are urgently needed [2]. Medicinal plants
are rich sources of essential oils (EOs) and secondary metabolite compounds that are often used as
natural and safe medicines in the treatment of infectious diseases. Additionally, the combination
of antimicrobial agents (EO and antibiotics) may lead to synergistic effects against pathogens that
can reduce the side effects of antibiotics, enhance the bioavailability, lower the therapeutic dose, and
minimize the antimicrobial resistance [3].
The Litsea genus is one of the most diverse genera of evergreen trees or shrubs in the Lauraceae
family, comprising roughly 400 species over the world [4]. The Litsea cubeba species is frequently
found in southern China, Japan, Taiwan, and South-East Asia including Vietnam, and is widely and
safely used in cosmetics, and traditional medicine for the treatment of headache, fatigue, muscle pain,
depression, sores and furuncles [5–7]. Interestingly, L. cubeba EO exhibits considerable bioactivities
such as antibacterial [8], antifungal [9], antioxidant [10], and anticancer activities [11]. Furthermore,
rich-EO-content medicinal plants like L. cubeba and Cinnamomum spp. could also be one of the prevalent
sources for antibiotic-producing endophytic actinobacteria conveying novel features [12,13]. In fact,
it has been previously demonstrated that the ecology and evolution of endophytic microorganisms
might be affected by the chemical compositions of host plant EO and the participation of endophytes
in the biotransformation of EO [14].
Our previous study primarily explored the accelerated antibacterial effects of the cell-free
supernatant of an isolated endophytic actinomycete and L. cubeba EO [8]. Nevertheless, further
study providing additional insights into the synergistic interactions between endophyte-derived
secondary metabolites and EO from host medicinal plants should be addressed, which may generate a
potential strategy to combat the emergence and spread of multidrug-resistant pathogens. Therefore,
the present study aimed to characterize the broad-spectrum antibacterial producing endophyte
Streptomyces griseorubens MPT42 associated with L. cubeba and evaluate the combinatory antimicrobial
activities of the crude ethyl acetate extract (CEAE) of the culture broth of S. griseorubens MPT42
and fruit EO of the host plant against various pathogens including multidrug-resistant bacteria.
In addition, the effects of the L. cubeba EO on the bacterial cell viability and morphology of a model
Escherichia coli were also investigated to reveal the possible mode of action for the combination of CEAE
and EO. Although vancomycin seems to have no effect on Gram-negative bacteria, a recent study
showed that the combination of vancomycin with other antibiotics displayed a strong synergic effect
against Gram-negative bacteria [15]. Therefore, the present study examined the potential synergistic
interactions of EO with erythromycin (a broad-spectrum antibacterial substance) or vancomycin (a
Gram-positive antibacterial substance) against various Gram-positive and negative pathogens.
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2. Results
2.1. Identification and Characterization of Antibiotic-Producing Endophytic Actinomycete MPT42
In order to screen the antibacterial activity of isolates, 35 out of 143 endophytic actinomycetes
potentially producing antibiotics were isolated from different organs of L. cubeba (Lour.) Pers plants [16].
Among them, the strain MPT42 isolated from the stem of the host plant inhibited the growth of the
majority of tested bacteria with inhibitory zones ranging from 11.4 to 44.0 mm (Table 1).
Table 1. Antibacterial activity of the cell-free supernatant of endophytic actinomycete MPT42 against
selected bacteria including pathogens.
Bacterial Species Zone of Inhibition (D ± SD, mm) #
Gram-positive bacteria
Listeria innocua ATCC 33090 27.5d ± 0.5
Staphylococcus aureus ATCC 25923 44.0a ± 2.0
Bacillus cereus ATCC 13061 18.0f ± 2.0
Bacillus subtilis ATCC 11778 36.3b ± 1.1
MRSE 28.2d ± 0.5
Gram-negative bacteria
Escherichia coli ATCC 25922 32.3c ± 0.4
Salmonella Typhimurium ATCC 14028 24.8e ± 0.9
Proteus vulgaris ATCC 49132 11.4h ± 0.4
Pseudomonas aeruginosa ATCC 9027 17.2g ± 0.9
Enterobacter aerogenes ATCC 13048 18.3f ± 0.4
#: Mean of diameter of inhibition zone (D) ± standard deviation (SD) of three replicates. Mean values with different
letters (a–h) are significantly different according to the Fisher LCD test (P < 0.05).
On ISP2 agar medium, aerial mycelium color of the MPT42 colonies was changed from white to
gray after five days of cultivation (Figure 1A) and none of the pigments was observed until 30 days.
The spore chain consisted of oval-shaped spores with spiral and spiny surfaces (Figure 1B).
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Figure 1. Colony morphology (A) and scanning electron microscope showing the spore-chain 
morphology and spore-surface ornamentation of the endophytic actinomycete strain MPT42 grown 
on ISP2 agar medium for 14 days at 28 °C at a magnification of 7500× (B). 
The physiological characteristics of strain MPT42 are described in the Table 2, which exhibited 
well-aerobic growth on an ISP2 medium at pH 8.0, temperature of 35 °C, and NaCl concentration of 
1%. The strain MPT42 can utilize different 11 carbon and 10 nitrogen sources (Table 2). In addition, 
the PCR results revealed that endophytic actinomycete MPT42 possessed three secondary metabolite 
biosynthetic genes: pks-I, pks-II, and nrps (Table 2). 
Table 2. Physiological and biochemical characteristics of the actinomycete MPT42. 
Characteristic Result  Characteristic Result 
Morphological Characteristics  Fructose + 
Aerial mycelium  Grey and white  Rhamnose + 
Substrate mycelium  Faint-brown  Saccharose − 
Diffusible pigment  −  Sorbitol + 
Spore chain  Spiral  Trehalose + 
Spore surface Spiny  Asparagin  + 
Spore shape Oval-shaped  Histidine  − 
(A) (B) 
Figure 1. Colony morphology (A) and scanning electron icroscope sho ing the spore-chain
orphology and spore-surface ornamentation of the endophytic actinomycete strain MPT42 grown on
ISP2 agar medium for 14 days at 28 ◦C at a magnification of 7500× (B).
i l t ristics f str i 42 r scri e i t
◦
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Analysis of the 16S rRNA gene sequence identified the strain MPT42 as a member of the
Streptomyces genus (homolo y of 99.5–100%). The neighbor-j ining phylogen tic tree indicated the
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close relationship between strain MPT42 and related Streptomyces species and showed the highest
homology to Streptomyces griseorubens type strain NBRC 12780 (bootstrap value of 100%, Figure 2),
therefore, it was assigned as Streptomyces griseorubens MPT42.
Table 2. Physiological and biochemical characteristics of the actinomycete MPT42.
Characteristic Result Characteristic Result
Morphological Characteristics Fructose +
Aerial mycelium Grey and white Rhamnose +
Substrate mycelium Faint-brown Saccharose −
Diffusible pigment − Sorbitol +
Spore chain Spiral Trehalose +
Spore surface Spiny Asparagin +
Spore shape Oval-shaped Histidine −
Physiological Properties Phenylalanin −
Temperature range for growth 25–37 ◦C Leucin +
Optimum temperature 35 ◦C Tryptophan +
pH range for growth 6–10 Arginin +
Optimum pH 8 Isoleucin +
NaCl range for growth 0.5–5% Valin +
Optimum NaCl 1% Methionin +
Biochemical Properties Lysin +
Glucose + Threonin +
Galactose + Cystein +
Mantose + Manitol +
Lactose − Biosynthetic Genes
Arabinose + pks-I +
Glucosamine + pks-II +
Myo-inositol + nrps +
+ Positive; − negative.
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2.2. Antimicrobial Activity of the Crude Ethyl Acetate Extract (CEAE) and Essential Oil (EO)
The CEAE of S. griseorubens MPT42 inhibited the growth of 13 tested microbes at different levels
(Table 3). Briefly, it was highly active (MICs ≤ 100 µg/mL) against S. aureus, E. coli, and S. Typhimurium,
while the MICs were moderate (between 200 and 600 µg/mL) toward B. subtilis, A. hydrophila, V.
parahaemolyticus, B. cereus, P. aeruginosa, L. innocua, and P. vulgaris [17]. For methicillin-resistant
Staphylococcus epidermidis ATCC 35984 (MRSE) and methicillin-resistant Staphylococcus aureus ATCC
33591 (MRSA), the MICs were 0.4 and 1.5 mg/mL, respectively.
Table 3. Antimicrobial activity of S. griseorubens MPT42-CEAE and L. cubeba fruit EO against microbial
strains including pathogens.
Bacteria
MIC of Antimicrobial Agents (mean ± SD, µg/mL)
EO CEAE Erythromycin Vancomycin
Gram-positive bacteria
Bacillus cereus ATCC 13061 2800 ± 0 300 ± 0 6.7 ± 2.3 1.0 ± 0
Bacillus subtilis ATCC 11778 2800 ± 0 200 ± 0 10.7 ± 4.6 2.0 ± 0
Staphylococcus aureus ATCC 25923 2800 ± 0 80 ± 0 0.7 ± 0.3 1.0 ± 0
MRSA 3700 ± 1.6 1500 ± 0 4.0 ± 0 2.0 ± 0
MRSE 3700 ± 1.6 400 ± 0.1 8.0 ± 0 3.3 ± 1.2
Listeria innocua ATCC 33090 1200 ± 0.4 600 ± 0 16.0 ± 0 16.0 ± 0.6
Gram-negative bacteria
Aeromonas hydrophila ATCC 35654 2800 ± 0 600 ± 0 128.0 ± 0 128.0 ± 0
Escherichia coli ATCC 25922 5500 ± 0 100 ± 0 32.0 ± 0 64.0 ± 0
Proteus vulgaris ATCC 49132 700 ± 0 600 ± 0 16.0 ± 0 64.0 ± 0
Pseudomonas aeruginosa ATCC 9027 2300 ± 0.8 400 ± 0.1 256.0 ± 0 32.0 ± 0
Salmonella Typhimurium ATCC 14028 5500 ± 0 100 ± 0 64.0 ± 0 64.0 ± 0
Vibrio parahaemolyticus ATCC 17802 5500 ± 0 200 ± 0 42.7 ± 18.5 128.0 ± 0
Analysis of the chemical constituents by gas chromatography-mass spectrometry showed that
the main compositions of 98%-purity EO were citral (36.0%), carveol (29.6%), and limonene (20.5%).
Interestingly, the antimicrobial activity of the individual substances has been reported previously [9,18].
Here, we examined the antimicrobial activity of the total EO constituents to explore potential synergistic
effects. Nevertheless, in concordance with a previous study [9,19], the L. cubeba EO showed low MICs
(≥ 700 µg/mL) against the tested microbes (Table 3) [17].
2.3. Effect of the L. cubeba EO on Viability and Cell Morphology of E. coli
Time-killing assays showed that the viability of E. coli ATCC 25922 cells was gradually reduced
according to the increase in EO concentration (Figure 3), where the living cells were not detected after
5–7 h of incubation at EO concentrations of 2 and 1 MIC, respectively (MIC = 5.5 mg/mL). In the
EO-free wells, the concentration of living cells was dramatically increased (reaching 10 log10 CFU/mL
after 7 h). In contrast, over 4.2 log10 CFU/mL (50% reduction) of the cell viability compared with the
initial cell concentration was obtained at 2 MIC (3.74 log10 CFU/mL) and 1 MIC (3.77 log10 CFU/mL) of
the EO concentrations after 1 and 5 h, respectively.
Cell viability evaluated by using the LIVE/DEAD BacLight viability kit revealed that the number
of intact cells decreased significantly in the culture treated with the EO (0.5 and 1 MIC) compared to
the control (Figure 4A–C). Moreover, proportions of the membrane-damaged cells were over 62% in
the treated samples, whereas this proportion was only 2.5% in the control (Figure 4D).
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Figure 3. Time–kill kinetics L. cubeba fruit EO on the v ability of E. coli ATCC 25922 (n = 3 ±
SD). The bacterial cells we treated with differe t concentrations of EO (1, 2, 5, and 10 MIC) for 24 h.
The control was EO-untreated cells.
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Figure 4. Effects of L. cubeba fruit EO on the viability of E. coli ATCC 25922. Fluorescence microscopic
images with the LIVE/DEAD Baclight kit of E. coli cells after 2 h of exposure to the EO. Control:
EO-untreated cells (A); EO-treated cells at 0.5 MIC (B) and at 1 MIC (C), and proportion of permeabilized
cells (D). Viable cells are indicated by green fluorescence, whereas cells with damaged membranes are
indicated by red fluorescence. The white arrows indicate elongated cells (E) and the filament cells were
>6 µm in length. Scale bar represents 2 µm.
The morphology and size changes of the E. coli cells were examined on images of EO-treated
and EO-untreated cells (Figure 4E). The length of the bacterial cells expos d to EO dramatically
increased 1.3–1.4 fold (corresponding to 2.41 and 2.54 µm, respectively) when compared with the
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untreated cells (1.86 µm). Notably, the proportion of filament cells (length ≥ 6 µm) was 3% in the
1 MIC EO-treated E. coli populations. None of the elongated or filament cells was observed in the
EO-untreated bacterial populations.
2.4. Combined Antimicrobial Effects Against Microbial Strains
To enhance antimicrobial potencies, the combinations of CEAE with EO were tested against the
12 microbial species including several pathogens (Table 4). The vast majority of the combinations
significantly decreased MIC from 4 to 16 folds when compared with the use of CEAE and EO separately.
Specifically, the combinations of CEAE-EO led to synergistic antimicrobial interactions (n = 8) against B.
cereus, B. subtilis, S. aureus, MRSE, L. innocua, A. hydrophila, E. coli, and P. aeruginosa. An additive effect
(n = 3) was observed toward MRSA, Proteus vulgaris, and Vibrio parahaemolyticus (Table 4). The highest
antimicrobial synergy was found for the combination of CEAE–EO against L. innocua and MRSE (FIC
= 0.19) (Table 4).
Table 4. Interaction between L. cubeba fruit EO and CEAE, antibiotics expressed as the fractional
inhibitory concentration (FIC) index.
Bacterial Species
Combined EO and Antimicrobial Agents
CEAE E VA
MIC
(µg/mL)
FIC Index* (mean
± SD)
MIC
(µg/mL)
FIC Index *
(mean ± SD)
MIC
(µg/mL)
FIC Index* (mean
± SD)
Gram-positive Bacteria
B. cereus ATCC 13061 20 0.31 ± 0.0 (S) 0.56 0.25 ± 0.06 (S) 1.0 1.1 ± 0.04 (I)
B. subtilis ATCC 11778 50 0.31 ± 0.0 (S) 0.89 0.21 ± 0.04 (S) 0.21 0.35 ± 0.04 (S)
S. aureus ATCC 25923 10 0.27 ± 0.04 (S) 0.04 0.19 ± 0.00 (S) 0.08 0.21 ± 0.04 (S)
MRSA ATCC 33591 380 0.58 ± 0.14 (A) 0.67 0.23 ± 0.07 (S) 0.05 0.50 ± 0.0 (A)
MRSE ATCC 35984 50 0.19 ± 0.0 (S) 2.67 0.42 ± 0.13 (S) 1.65 0.58 ± 0.04 (A)
L. innocua ATCC 35984 40 0.19 ± 0.0 (S) 2.0 0.63 ± 0.11 (A) 3.33 0.38 ± 0.0 (S)
Gram-negative Bacteria
A. hydrophila ATCC 35654 60 0.35 ± 0.04 (S) 42.7 0.54 ± 0.07 (A) 8.0 0.31 ± 0.0 (S)
E. coli ATCC 25922 20 0.27 ± 0.04 (S) 4.0 0.23 ± 0.04 (S) 16.0 0.56 ± 0.0 (A)
P. vulgaris ATCC 49132 60 0.60 ± 0.04 (A) 1.33 0.33 ± 0.04 (S) 26.7 0.54 ± 0.04 (A)
P. aeruginosa ATCC 9027 100 0.31 ± 0.0 (S) 21.3 1.08 ± 0.04 (I) 2.67 0.33 ± 0.04 (S)
S. Typhimurium ATCC 14028 6 1.06 ± 0.0 (I) 32.0 0.56 ± 0.0 (A) 53.3 1.83 ± 0.29 (I)
V. parahaemolyticus ATCC 17802 100 0.56 ± 0.0 (A) 14.2 0.58 ± 0.14 (A) 26.7 0.54 ± 0.07 (A)
CEAE: crude ethyl acetate extract; E: Erythromycin; VA: Vancomycin. * Synergism (S): ΣFIC < 0.5; Additive (A): 0.5
≤ ΣFIC ≤ 1; Indifferent (I): 1 < ΣFIC ≤ 4 [20,21]. NA: Not applicable.
In the present study, the combinations of EO with either antibiotics E or VA also increased the
antimicrobial effects toward the microbial species tested. Almost all of these antibiotic–EO combinations
led to a decrease of 2–16 MIC folds when compared with the single use of E or VA. Specifically, the
combinations of E with EO also led to seven synergistic and four additive effects, while the VA–EO
combinations resulted to 10 synergistic—additive effects (Table 4). It is worth noting that the VA–EO
combinations exhibited three synergistic antimicrobial effects on Gram-negative bacteria A.s hydrophila
and P. aeruginosa (FICIs of 0.31 and 0.33, respectively), and additive effects toward E. coli, P. vulgaris
and V. parahaemolyticus (FICIs between 0.54 and 0.56).
3. Discussion
So far, S. griseorubens species has mainly been found in soils [12,22,23] and was previously
demonstrated as a strong antagonistic species conveying broad antifungal activities [24]. The present
research revealed for the first time the activity of the endophytic actinomycete S. griseorubens MPT42
isolated from the stem of L. cubeba. Its CEAE extract exhibited a broad-spectrum antimicrobial
activity toward various microbial types including drug-sensitive and multidrug-resistant pathogens.
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It showed moderate—strong inhibitory effects with MICs values between 80–600 µg/mL on 10 different
microbes. Since many novel antibiotics exhibiting strong effects against multiple-drug resistant
bacteria have been isolated from medicinal plant-associated endophytic Streptomyces spp. in the last
decades [22,25–28], endophytic S. griseorubens MP42 could be a potential candidate for the production
of valuable bioactive substances.
In agreement with previous reports [9,18,29], the present study demonstrated the potential growth
inhibiting effect of L. cubeba EO (MICs of 0.70–5.5 mg/mL) toward a broad array of microbial species,
compared with EOs derived from other medicinal plants. For instance, Ocimum gratissimum EO
inhibited both Gram-positive bacteria (S. aureus and Bacillus spp.) at the concentration of 93.7–150
mg/mL and Gram-negative bacteria (E. coli, P. aeruginosa, S. Typhimurium, Klebsiella pneumoniae, Proteus
mirabilis) at the concentration of 107–750 mg/mL [30]. Another study showed that Cinnamomum EO
(Lauraceae family) possessed low MIC values ranging from 1.2 to 12.5 mg/mL against E. coli, C. jejuni, S.
aureus, S. enteritidis, S. Typhimurium, L. innocua, and L. monocytogenes [31,32]. Thus, different chemical
constituents in the EO of medicinal plant species affect their potential antimicrobial activity. Using E.
coli as a model for exploring the mechanism of action of L. cubeba fruit EO, we demonstrated that
EO-treated cells were rapidly killed after 2 h of treatment at the EO concentrations ≥ 2 MIC. It is
worth noting that the cells showed extraordinary deformation and elongation. Our study found citral,
carveol, and limonene as the main constituents, accounting together for 86.1% of total L. cubeba fruit EO,
concordant with previous studies [9,18]. Since the effect of each substance on microbes was examined
separately in these studies, therefore, the present study aimed at investigating the antimicrobial
inhibitory effects possessed by the total EO. This combination showed broad-spectrum inhibitory
effects against various microbial species tested. In fact, citral, carveol, and limonene are phenolic
substances with polarity characteristics that might act on the bacterial cell membrane, inactivate cell
adhesions, and/or interact with the outer and inner membrane proteins [19,29,33,34]. Consequently, the
EO treatment might result in the weakening of cell structure and inhibition of cell growth by creating
holes on the cell wall and increasing the cell permeability [29].
Since the modes of action of EO and antibiotics on microorganisms are different, the combination
of both agents could enhance antimicrobial effects. The present study also found that combinations
of EO with the CEAE of S. griseorubens MP42 or with either E or VA significantly reduced the MIC
values on almost all microbes tested in comparison with the individual effects (MIC reductions of 4–16
folds and 2–16 folds for CEAE and antibiotics, respectively), therefore showing significant synergistic
antimicrobial effects. Thus, the synergistic effects of S. griseorubens MPT42- extract and L. cubeba fruit
EO might be due to the fact that EO disintegrates the bacterial cell membrane, influences the cell wall
structure, forming holes and gaps in the cell wall [3,29,35,36]. These processes make antibiotic-like
substances diffusive inside bacterial cells, where they might then inhibit metabolic processes, protein
and/or DNA synthesis, etc., leading to cell death [3,29,37]. Although combinations of different types
or generations of antibiotics have shown synergistic effects [38,39], the use of an appropriate EO
in combination with antibiotics against bacterial pathogens could bring advantageous alternatives
to reducing the use of conventional antibiotics as well as the emergence of multidrug-resistant
bacteria [40]. For instance, streptomycin and kanamycin combined with lemongrass (Cymbopogon
citratus) EO exhibited synergistic or additive effect against S. Typhimurium [37]. The combination of
gentamicin or tobramycin with tea tree (Melaleuca alternifolia) EO had a synergistic effect against both
E. coli and S. aureus [37]. Notably, VA combined with Shiraz oregano (Zataria multiflora) EO showed
synergistic activity against MRSA [35]. It is well known that Gram-negative bacteria are normally
resistant to VA as this antibiotic cannot significantly penetrate the outer membrane of cells. In the
present study, the use of VA was not as the control for the inhibitory growth of Gram-negative bacteria,
but aimed to discover the potential synergistic antimicrobial effects of VA–EO against Gram-negative
bacteria. We found that in the presence of EO, the MICs of VA toward Gram-negative bacteria were
significantly reduced and had strong synergistic inhibitory effects for A. hydrophila and P. aeruginosa,
and additive effects on E. coli, P. vulgaris, and V. parahaemolyticus. This finding could be explained
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though two mechanisms: first, the EO could increase the permeability of the cell wall that allows the VA
diffusion inside cells; second, interactions between VA and other antimicrobial substances of EO lead
to synergistic antimicrobial effects. In fact, the drug interaction network possesses a special property,
and in many cases, the antibiotics interact purely synergistically, leading to increased antibacterial
activity [41]. A study showed that the combination of VA with either nitrofurantoin or trimethoprim
had a strong synergic effect against E. coli at concentrations of VA as low as 6.25 µg/mL [15]. The result
of our study demonstrated that the EO–VA combination increased antimicrobial inhibitory activities
against Gram-negative bacteria when compared with the individual effect of VA. Altogether, our study
underlines that the combination of antimicrobial substances with the EO of medicinal plants brings
greater and broader effects toward various pathogens and that the synergy can lead to multi-targeted
effects on the inhibition of microbial growth and viability.
4. Materials and Methods
4.1. Screening for Antibacterial Activity
The antibacterial activity of endophytic actinomycete MPT42 was examined by using the agar
diffusion method [42] against Gram-negative bacteria (Escherichia coli ATCC 25922, Proteus vulgaris
ATCC 49132, Pseudomonas aeruginosa ATCC 9027, Salmonella Typhimurium ATCC 14028, and Enterobacter
aerogenes ATCC 13048) and Gram-positive bacteria (Listeria innocua ATCC 33090, Bacillus cereus ATCC
13061, Bacillus subtilis ATCC 11778, Staphylococcus aureus ATCC 25923, and Methicillin-Resistant
Staphylococcus epidermidis ATCC 35984 (MRSE).
4.2. Characteristics of the Endophytic Actinomycete MPT42
The strain MPT42 was cultured at 28 ◦C on International Streptomyces Project 2 (ISP2) agar
medium for 14 days to characterize the biophysical-biochemical properties [43,44]. The spore chain
morphology and spore ornamentation were analyzed by scanning electron microscope (SEM) JSM-5410
(JEOL, Tokyo, Japan) at a magnification of 7500x. The effects of different conditions (ranges of pH,
NaCl concentration and temperature, carbon and nitrogen sources) to the growth were investigated as
previously described [45].
4.3. Amplification of Secondary Metabolite Biosynthetic Genes and 16S rRNA Encoding Gene
The amplification of the 16S rRNA gene sequence of actinomycete MPT42 was performed
by using the universal primer pair 27F (5′-TAACACATGCAAGTCGAACG-3′) and 1429R
(5′-GGTGTGACGGGCGGTGTGTA-3′) [46]. The multiple sequence alignment was employed for
the MPT42 and type strains (sequences retrieved from GenBank, National Center for Biotechnology
Information (NCBI)) by using MEGA6 [47]. The phylogenetic tree was computed by using the
neighbor-joining method with 1000 bootstrap in MEGA6 [47] and Bacillus thuringiensis strain ATCC
10792 (NR_114581) was used as the outgroup branch. The 16S rRNA gene sequence of strain MPT42
was deposited at GenBank (NCBI) under the accession number MG021134.
The presence of genes non-ribosomal polyketide synthases (nrps), polyketide synthase type I
(pks-I), and type II (pks-II) encoding for secondary metabolite biosynthesis in actinomycetes was
explored by using three sets of degenerated primer pairs A3F (5’-GCS TAC SYS ATS TAC ACS TCS
GG-3’) and A7R (5’-SAS GTC VCC SGT SCG GTA S-3’), K1F (5’-TSA AGT CSA ACA TCG GBC A-3’)
and M6R (5’-CGC AGG TTS CSG TAC CAG TA-3’), KSaF (5’-TSG CST GCT TGG AYG CSA TC-3’),
and KSaR (5’-TGG AAN CCG CCG AAB CCG CT-3’), respectively [48,49]. PCR components and
conditions were performed as previously described [50].
4.4. Preparation of L. cubeba Fruit EO and CEAE From MPT42 Culture
The L. cubeba fruit EO were extracted by hydro-distillation using a Clevenger-type apparatus for
4 h, and then dried over anhydrous sodium sulfate. Finally, the EO density obtained was 0.88 g/mL
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(98% purity) and it was stored at 4 ◦C in a dark bottle until use. The L. cubeba fruit EO was then
completely dissolved in distilled water supplemented with 0.5% Tween 80 (an emulsifier usually used
to dissolve EOs in water) to achieve final concentrations ranging from 0.25 mg/mL to 64 mg/mL.
The strain MPT42 was cultivated in YIM38 antibiotic-producing medium at 28 ◦C with 200 rpm
shaking. After five days, the culture broth was centrifuged and the cell-free supernatant (CFS) was
extracted with ethyl acetate (1:1, v/v) and evaporated to determine the weight of CEAE. After that, the
CEAE solution was prepared in ethanol with the concentration ranging from 0.0625 to 16 mg/mL.
4.5. Determination of Minimum Inhibitory Concentration
The minimum inhibitory concentrations (MICs) of the CEAE and EO were determined separately
by using serial microdilution assays [7] against 12 bacterial species: E. coli, P. vulgaris, P. aeruginosa, S.
Typhimurium, L. innocua, B. cereus, B. subtilis, S. aureus, MRSE, Aeromonas hydrophila ATCC 35654, Vibrio
parahaemolyticus ATCC 17802, and methicillin-resistant Staphylococcus aureus (MRSA) ATCC 33591.
For each microorganism, suspensions were prepared in Mueller Hilton broth (MHB, Merck) to
obtain the final concentration of 107 CFU/mL. Each well contained 20 µL of the CEAE or EO and 180 µL
of each bacterial suspension. After incubation 24 h at 30 ◦C for A. hydrophila and V. parahaemolyticus
and at 37 ◦C for the other strains, the optical density (OD) was measured at 600 nm using a microplate
reader (Bio-Rad Model 680, Japan). All experiments were performed in triplicate. The MIC value
was determined as the lowest concentration showing the inhibition of bacterial growth. The standard
antibiotics erythromycin (E) and vancomycin (VA) were used to evaluate the synergetic antimicrobial
effects of the EO–antibiotic combinations by a microdilution checkerboard assay (described below).
The antibiotic concentrations were prepared in a range from 0.25 to 512 µg/mL, and the test was
performed under the same conditions.
4.6. Time-Killing Assay
In order to investigate the activity of the L. cubeba EO against pathogenic bacteria, the time-kill
curve assay was performed using E. coli ATCC 25922 as a model [19]. The experiments were designed
as follows: tubes including bacterial suspension (108 CFU/mL) were exposed to four different EO
concentrations (1, 2, 5, and 10 MIC) and control tube (bacterial culture without EO). The tubes were
incubated at 37 ◦C for 24 h with stirring at 120 rpm/min. Total viable bacteria were enumerated by
spreading 100 µL of culture on Muller Hinton agar plates and after 0, 1, 3, 5, 7, and 24 h of incubation at
37 ◦C, bacterial colonies were counted and the bacterial concentration was expressed as log10 CFU/mL.
Assays were carried out in triplicate.
4.7. Effects of L. cubeba EO on Bacterial Cell Viability and Morphology
The effect of the L. cubeba fruit EO on cell viability was evaluated using the LIVE/DEAD BacLight
viability kit (InvitrogenTM, Molecular Probes Inc., OR, USA) [19]. Briefly, the E. coli cultures were
prepared in MHB as described above, then each tube containing 5 mL of cell suspension was
incubated with 1 MIC and 0.5 MIC of the EO at 37 ◦C. After 2 h of exposure, the cells were harvested by
centrifugation at 10,000x g for 10 min, then the supernatant was removed and pellets were re-suspended
in NaCl 0.85%. The mixture of SYTO 9 and propidium iodide (PI) was added into the suspension with
the ratio of 1:1. The cell suspension with 0.5% Tween 80 (v/v) and without EO was used as the control.
After 15 min of staining, cells were examined under the microscope on 1% agarose (in water)-covered
slides. Using a LEICA DM6000 photomicroscope equipped with an ORCA-ER C4742-80 camera
(Hamamatsu, Japan), at least 20 photomicrographs were taken of different fields of view as previously
described [51]. The percentages of cells stained with PI (permeabilized cells) and SYTO 9 (viable cells)
were determined.
The effect of EO on the size of bacterial cells was evaluated by analyzing fluorescence microscopy
images with ImageJ [19]. E. coli cell length was measured and recorded with and without the EO
treatment. Cell length was measured as the distance along the two axes of the cell. The dividing cells
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that were not separated yet were counted and measured as one single cell. Cells were counted as two
separated cells only when the constriction was completed. At least 1000 cell sizes were measured for
each experiment. Filament cells were considered when the cell length was ≥6 µm.
4.8. Microdilution Checkerboard Assays
The checkerboard method was performed using 96-well microtiter plates to obtain the fractional
inhibitory concentration (FIC) index for determining the interaction between the CEAE and EO; and
those between EO and antibiotics (E and VA) [21]. Serial two-fold dilutions were prepared to examine
the combinatory antimicrobial activity of the CEAE and EO (25 pair combined concentrations from
0.0625 MIC to 1 MIC). For each well, 20 µL CEAE and 20 µL EO were inoculated with 160 µL of each
bacterial suspension (107 CFU/mL). The plates were then incubated 24 h at 30 ◦C for A. hydrophila
and V. parahaemolyticus and at 37 ◦C for the other strains. The FIC index was calculated as: ΣFIC
= FICCEAE + FICEO, where FICCEAE = MICCEAE combination/MICCEAE alone and FICEO = MICEO
combination/MICEO alone. The interaction results were interpreted as synergy (ΣFIC < 0.5), addition
(0.5 ≤ ΣFIC ≤ 1), indifference (1 < ΣFIC ≤ 4), or antagonism (ΣFIC > 4) [21]. All experiments were
performed in triplicate. Antibiotics E and VA were also included in the assay with the ratio of
concentrations ranging from 0.0625 to 1 µg/mL.
4.9. Statistical Analysis
The data were expressed as mean ± standard deviation (SD) of three replicates. The MIC and FIC
values of the CEAE and EO were analyzed by one-way analysis of variance (ANOVA), followed by a
Fisher’s least significant difference (LSD) at the threshold of P < 0.05.
5. Conclusions
This study underlines that the endophytic actinomycete S. griseorubens MPT42 associated with
medicinal plant L. cubeba can be a potential producer of broad-spectrum antimicrobial substances.
The cytotoxic effect of L. cubeba EO was explored to understand its mode of action on E. coli cells.
Moreover, the combination of S. griseorubens MPT42-extract and EO from the host plant revealed
remarkable synergistic antimicrobial effects toward various microbes, and this synergy was equivalent
to those between EO and antibiotics (E and VA). In the presence of EO, the MIC of VA was decreased
on all Gram-negative bacteria tested and exhibited five additive–synergistic effects. These results
underline that the combined antibiotic–EO and CEAE–EO would be an effective strategic choice to
reduce the use of antibiotics and fight the emergence and spread of multidrug-resistant microbes.
Further studies aim to isolate S. griseorubens MPT42-derived antimicrobial substances for determining
their mode of action and molecular targets.
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